PCRS-UK Asthma Audit
Data collection form - Use 1 per patient
Practice ID: Your membership Number:- ____________________ (see member email about this audit if you do not know your membership number or contact us
at info@pcrs-uk.org)
Patient ID number for audit ________________________
(use sequential numbering starting with 1 for the first patient – do not use the real patient ID
number)
Patient age range (minimum 5 years of age)
 Child
 Teenager  Adult
Real Patient ID ________________________ For your reference only – not to be recorded on the audit system
1.
Who saw the patient last for a review of their asthma or during an acute asthma episode?
(For this we suggest you ask the patient and confirm via patient records if possible)

Asthma specialist nurse / practice nurse (with asthma diploma)

Practice nurse

GP

Secondary care specialist (physician / nurse)

A&E / Out of hours / emergency services
2.
Is the preventer medication being taken as expected over the last year?
(For this we suggest you check on the number of prescriptions given over the last year and discuss with the patient)

More than would be expected

Close to perfect preventative medication uses (around 3/4 of expected or more)

Some problems with preventative medication use (around 1/3 to 3/4 of expected use)

Poor preventative medication use (less than 1/3)
1
PCRS-UK Asthma Audit
3.




How many SABA inhalers have been prescribed in the last year for this patient?
1-2 inhalers
3-6 inhalers
7-11 inhalers
12 or more SABA inhalers
4.
How good is symptom control?
(Answer based on RCP 3 questions – see also http://www.pcrs-uk.org/rcp-3-questions)




Good control ('no' to all three questions)
Likely to have good control (1 positive response)
Likely to be poorly controlled and needs further assessment (2 positive responses)
Poor control (3 positive responses)
Interpretation of the RCP three questions (RCP3Q) scores in clinical practice
RCP3Q
Interpretation
0
Good control
1
2
Likely to have good control (1 positive response)
Likely to be poorly controlled and needs further
assessment (2 positive responses)
3
Poorly controlled
Exacerbations and use of reliever inhalers reflect a different aspect of control and
should be explored independently
2
RCP 3 questions (Asthma)
The Royal College of Physicians (RCP) '3 Questions' are widely
used:
1.
In the last month / week have you had difficulty sleeping
due to your asthma (including cough symptoms)?
2.
Have you had your usual asthma symptoms (e.g. cough,
wheeze, chest tightness, shortness of breath) during the
day?
3.
Has your asthma interfered with your usual daily activities
(e.g. school, work, housework)?
Note: one 'yes' indicates medium morbidity and two or
three 'yes' answers indicate high morbidity.
PCRS-UK Asthma Audit
5.
How many unused / unopened reliever inhalers does the patient have? (SABA only)?
_______quantity
6.



Does the patient routinely order additional supplies of SABA when they obtain their repeat prescription irrespective of whether they require their SABA
prescription to be filled?
Yes
Yes, Pharmacist orders this for the patient
No
7. Does the patient pay for prescriptions?

Yes (per item)

Yes, Bulk Pre-payment

No
NOW ENTER THIS PATIENT’S RESULTS ON THE ONLINE SYTEM AVAILABLE HERE AND FILE FORM WITH PATIENT RECORD
http://www.pcrs-uk.org/training/pcrs-uk-2013-audit-compliance-and-concordance-asthma
The Primary Care Respiratory Society, formerly known as the General Practice Airways Group, is a registered charity
(Charity No: 1098117) and a company limited by guarantee registered in England (Company No: 4298947)
VAT Registration Number: 866 1543 09. Registered offices: 2 Wellington Place, Leeds, LS1 4AP
Registered offices: PCRS-UK, Unit 2, Warwick House, Kingsbury Road, Curdworth, Sutton Coldfield, B76 9EE
Telephone: +44 (0)1675 477600
Facsimile: +44 (0) 121 336 1914 Email: info@pcrs-uk.org
The Primary Care Respiratory Society UK is grateful to its corporate supporters including Allen & Hanburys (the respiratory division of GlaxoSmithKline), Almirall Ltd, AstraZeneca UK Ltd, Boehringer
Ingelheim Ltd, Chiesi Ltd, Napp Pharmaceuticals, Novartis UK, Orion Pharma (UK) Ltd and TEVA UK Limited for their financial support which supports the core activities of the Charity and allows the
3 or at greatly reduced rates to its members.
PCRS-UK to make its services either freely available